Back to results
US 2007/0179140 A1Published application
Stereoisomerically Enriched 3-Aminocarbonyl Bicycloheptene Pyrimidinediamine Compounds And Their Uses
AssigneeRigel Pharmaceuticals, Inc.
InventorsAnkush Argade, Rajinder Singh, Hui Li
Life of this patent
Estimating the term…
Abstract
The present invention provides stereoisomers and stereoisomeric mixtures of 3-aminocarbonyl-bicycloheptene-2,4-pyrimidinediamine compounds having antiproliferative activity, compositions comprising the compounds and methods of using the compounds to inhibit cellular proliferation and to treat proliferate diseases such as tumorigenic cancers.
Claims2
A compound according to structural formula (1):
- including prodrugs, salts, hydrates, solvates and N-oxides thereof, that is enriched in the corresponding diastereomer of structural formula (Ia):
- wherein:
- each R1 is independently selected from the group consisting of hydrogen, lower alkyl, —(CH2)n—OH, —ORa, —O(CH2)n—Ra, —O(CH2)n—Rb, —C(O)ORa, halo, —CF3 and —OCF3;
- each R2 is independently selected from the group consisting of hydrogen, lower alkyl, —ORa, —O(CH2)n—Ra, —O(CH2)n—Rb, —NHC(O)Ra, halo, —CF3, —OCF3,
- each R3 is independently selected from the group consisting of hydrogen, lower alkyl, —(CH2),n—OH, —ORa, —O(CH2)n—Ra, —O(CH2)n—Rb, halo, —CF3, —OCF3,
- each R4 is independently selected from the group consisting of hydrogen, lower alkyl, arylalkyl, —OR , —NRcRc, —C(O)Ra, —C(O)ORa and —C(O)NRcRc;
- R5 is hydrogen, halo, fluoro, —CN, —NO2, CO2Ra or —CF3;
- each n is independently an integer from 1 to 3;
- each Ra is independently selected from the group consisting of hydrogen, lower alkyl and lower cycloalkyl;
- each Rb is independently selected from the group consisting of —ORa, —CF3, —OCF3, —NRcRc, —C(O)Ra, —C(O)ORa, —C(O)NRcRc and —C(O)NRaRd;
- each Rc is independently selected from the group consisting of hydrogen and lower alkyl, or, alternatively, two Rc substituents may be taken together with the nitrogen atom to which they are bonded to form a 5-7 membered saturated ring which optionally includes 1-2 additional heteroatomic groups selected from O, NRa, NRa—C(O)Ra, NRa—C(O)ORa and NRa—C(O)NRa;
- and
- each Rd is independently lower mono-hydroxyalkyl or lower di-hydroxyalkyl.
10 more elements
-49. (canceled)
Dependencies are inferred from the claim text.